SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-046949
Filing Date
2021-09-08
Accepted
2021-09-08 06:04:57
Documents
13
Period of Report
2021-09-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea147035-8k_inmedpharma.htm   iXBRL 8-K 33305
2 NEWS RELEASE, DATED SEPTEMBER 7, 2021 ea147035ex99-1_inmedpharma.htm EX-99.1 13316
  Complete submission text file 0001213900-21-046949.txt   223589

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20210907.xsd EX-101.SCH 3030
4 XBRL LABEL FILE inm-20210907_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE inm-20210907_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT ea147035-8k_inmedpharma_htm.xml XML 3638
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211240595
SIC: 2834 Pharmaceutical Preparations